Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Cyclosporin A in the treatment of acute exacerbation of idiopathic pulmonary fibrosis.

Sakamoto S, Homma S, Miyamoto A, Kurosaki A, Fujii T, Yoshimura K.

Intern Med. 2010;49(2):109-15. Epub 2010 Jan 15.

2.

Cyclosporin A followed by the treatment of acute exacerbation of idiopathic pulmonary fibrosis with corticosteroid.

Inase N, Sawada M, Ohtani Y, Miyake S, Isogai S, Sakashita H, Miyazaki Y, Yoshizawa Y.

Intern Med. 2003 Jul;42(7):565-70.

3.

Cyclosporin treatment in steroid-resistant and acutely exacerbated interstitial pneumonia.

Homma S, Sakamoto S, Kawabata M, Kishi K, Tsuboi E, Motoi N, Yoshimura K.

Intern Med. 2005 Nov;44(11):1144-50.

4.

[Effect of corticosteroids upon the prognosis of idiopathic pulmonary fibrosis].

Li ZH, Peng SC, Kang J, Hou XM, Yu RJ.

Zhonghua Yi Xue Za Zhi. 2010 Mar 30;90(12):804-7. Chinese.

PMID:
20450617
5.

Noninvasive ventilation in acute exacerbation of idiopathic pulmonary fibrosis.

Yokoyama T, Kondoh Y, Taniguchi H, Kataoka K, Kato K, Nishiyama O, Kimura T, Hasegawa R, Kubo K.

Intern Med. 2010;49(15):1509-14. Epub 2010 Aug 2.

6.

Polymyxin B-immobilized fiber column (PMX) treatment for idiopathic pulmonary fibrosis with acute exacerbation: a multicenter retrospective analysis.

Abe S, Azuma A, Mukae H, Ogura T, Taniguchi H, Bando M, Sugiyama Y.

Intern Med. 2012;51(12):1487-91. Epub 2012 Jun 15.

7.

Recombinant human soluble thrombomodulin treatment for acute exacerbation of idiopathic pulmonary fibrosis: a retrospective study.

Isshiki T, Sakamoto S, Kinoshita A, Sugino K, Kurosaki A, Homma S.

Respiration. 2015;89(3):201-7. doi: 10.1159/000369828. Epub 2015 Feb 5.

PMID:
25659984
8.

Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group.

Sawada K, Hirokawa M, Fujishima N, Teramura M, Bessho M, Dan K, Tsurumi H, Nakao S, Urabe A, Omine M, Ozawa K; PRCA Collaborative Study Group.

Haematologica. 2007 Aug;92(8):1021-8. Epub 2007 Jul 20.

9.

Tacrolimus and steroid treatment for acute exacerbation of idiopathic pulmonary fibrosis.

Horita N, Akahane M, Okada Y, Kobayashi Y, Arai T, Amano I, Takezawa T, To M, To Y.

Intern Med. 2011;50(3):189-95. Epub 2011 Feb 1.

10.

Acute exacerbation of idiopathic interstitial pneumonia following lung surgery in 3 of 68 consecutive patients: a retrospective study.

Sakamoto S, Homma S, Mun M, Fujii T, Kurosaki A, Yoshimura K.

Intern Med. 2011;50(2):77-85. Epub 2011 Jan 15.

11.

Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases.

Suda T, Kaida Y, Nakamura Y, Enomoto N, Fujisawa T, Imokawa S, Hashizume H, Naito T, Hashimoto D, Takehara Y, Inui N, Nakamura H, Colby TV, Chida K.

Respir Med. 2009 Jun;103(6):846-53. doi: 10.1016/j.rmed.2008.12.019. Epub 2009 Feb 1.

12.

Thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis: a proof of concept study.

Tsushima K, Yamaguchi K, Kono Y, Yokoyama T, Kubo K, Matsumura T, Ichimura Y, Abe M, Terada J, Tatsumi K.

Pulm Pharmacol Ther. 2014 Dec;29(2):233-40. doi: 10.1016/j.pupt.2014.04.008. Epub 2014 May 14.

PMID:
24836398
13.

Acute exacerbation of IPF following diagnostic bronchoalveolar lavage procedures.

Sakamoto K, Taniguchi H, Kondoh Y, Wakai K, Kimura T, Kataoka K, Hashimoto N, Nishiyama O, Hasegawa Y.

Respir Med. 2012 Mar;106(3):436-42. doi: 10.1016/j.rmed.2011.11.006. Epub 2011 Dec 3. Review.

14.

Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.

Abe M, Tsushima K, Matsumura T, Ishiwata T, Ichimura Y, Ikari J, Terada J, Tada Y, Sakao S, Tanabe N, Tatsumi K.

Drug Des Devel Ther. 2015 Oct 23;9:5755-62. doi: 10.2147/DDDT.S90739. eCollection 2015.

15.

Autopsy analyses in acute exacerbation of idiopathic pulmonary fibrosis.

Oda K, Ishimoto H, Yamada S, Kushima H, Ishii H, Imanaga T, Harada T, Ishimatsu Y, Matsumoto N, Naito K, Yatera K, Nakazato M, Kadota J, Watanabe K, Kohno S, Mukae H.

Respir Res. 2014 Sep 1;15:109. doi: 10.1186/s12931-014-0109-y.

16.

Survival in Idiopathic pulmonary fibrosis acute exacerbations: the non-steroid approach.

Papiris SA, Kagouridis K, Kolilekas L, Papaioannou AI, Roussou A, Triantafillidou C, Baou K, Malagari K, Argentos S, Kotanidou A, Karakatsani A, Manali ED.

BMC Pulm Med. 2015 Dec 14;15:162. doi: 10.1186/s12890-015-0146-4.

17.

[Cyclosporin A treatment of interstitial pneumonia].

Homma S, Kawabata M, Kishi K, Tsuboi E, Narui K, Nakatani T, Matsushita H, Kurosaki A, Nakata K.

Nihon Kokyuki Gakkai Zasshi. 2003 Jul;41(7):427-33. Japanese.

PMID:
12931668
18.

Long-term efficacy of macrolide treatment in idiopathic pulmonary fibrosis: a retrospective analysis.

Kuse N, Abe S, Hayashi H, Kamio K, Saito Y, Usuki J, Azuma A, Kudoh S, Gemma A.

Sarcoidosis Vasc Diffuse Lung Dis. 2016 Oct 7;33(3):242-246.

PMID:
27758989
19.

Cyclosporin A treatment for idiopathic membranous nephropathy.

Yao X, Chen H, Wang Q, Tang Z, Hu W, Yin G, Liu Z, Li L.

Chin Med J (Engl). 2001 Dec;114(12):1305-8.

PMID:
11793859
20.

Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.

El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.

Nephrol Dial Transplant. 2005 Nov;20(11):2433-8. Epub 2005 Oct 4.

PMID:
16204303

Supplemental Content

Support Center